Richard M. Bergenstal
Richard M. Bergenstal publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and Surgery, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #26,371 of 7,710,434 ranked researchers
- Rank in United States
- #9,862 of 1,627,098
- Works
- 554
- Citations
- 60k
- Citations per work
- 107.6
What does Richard M. Bergenstal research?
Richard M. Bergenstal's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (13%), Health Professions (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences41875.4%
- Medicine40573.1%
- Health Professions132.3%
- Life Sciences7213.0%
- Everything else6411.6%
- 1Endocrinology, Diabetes and Metabolism61% of their works
- 2Genetics10% of their works
- 3Surgery9% of their works
- 4Molecular Biology4% of their works
- 5Physiology3% of their works
- 6General Health Professions2% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes and associated disorders
- Pancreatic function and diabetes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Metabolism, Diabetes, and Cancer
Which keywords describe Richard M. Bergenstal's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Type 1 Diabetes, Cardiovascular Disease, Continuous Glucose Monitoring, Hypoglycemia and Diabetes Mellitus.
- Metformin
- Self-Management
- Metabolic Syndrome
- ß-Cell Dysfunction
- Genetics
- Hyperglycemia
- Type 2 Diabetes
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Type 1 Diabetes
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Disease
- Hypoglycemia
- Cardiovascular Outcomes
- Critical Care
- Autoimmunity
- Pancreatic Islets
- Insulin Resistance
- Depression
- AMP-Activated Protein Kinase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycemic Control7894 topics
- Insulin Therapy7253 topics
- Diabetes5253 topics
- Type 1 Diabetes5232 topics
- Cardiovascular Disease4612 topics
- Continuous Glucose Monitoring3911 topic
- Hypoglycemia3911 topic
- Diabetes Mellitus2532 topics
- Cardiovascular Outcomes1941 topic
- Type 2 Diabetes1941 topic
- Critical Care1401 topic
- Hyperglycemia1401 topic
- Autoimmunity1321 topic
- Genetics1321 topic
- Pancreatic Islets1131 topic
- ß-Cell Dysfunction1131 topic
- Insulin Resistance701 topic
- Metabolic Syndrome701 topic
- Depression641 topic
- Self-Management641 topic
- AMP-Activated Protein Kinase421 topic
- Metformin421 topic
Where does Richard M. Bergenstal work?
Richard M. Bergenstal's main affiliation in the publication record is Park Nicollet Clinic, United States.
How many publications and citations does Richard M. Bergenstal have?
OpenAlex counts 554 works and 59,625 citations for Richard M. Bergenstal, an h-index of 102, ranking #26,371 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Richard M. Bergenstal
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Richard M. Bergenstal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.